Metabolic outcomes of bictegravir/emtricitabine/tenofovir alafenamide versus dolutegravir/lamivudine in treatment-naïve people living with HIV: a 48-week retrospective study
Yifan Guo(Capital University), Hongxin Zhao(Capital University), Yi Ding(Capital Medical University), Lulu Xing(Capital University), Chengyu Gao(Capital University), Qinlan Li(Capital University), Jiantao Fu(Beijing Ditan Hospital), Yi-Xiang Wang(Chinese Academy of Sciences), Jiang Xiao(Capital University), Yining Zhao(Capital University), Jialu Li(Capital University), Hongyun Zhao(Sun Yat-sen University)
Cited by 0
Related Papers
Multifunctional biohybrid magnetite microrobots for imaging-guided therapy
|Science Robotics|2017|873
Clinical Utility of In-house Metagenomic Next-generation Sequencing for the Diagnosis of Lower Respiratory Tract Infections and Analysis of the Host Immune Response
|Clinical Infectious Diseases|2020|195
Myeloid-derived itaconate suppresses cytotoxic CD8+ T cells and promotes tumour growth
|Nature Metabolism|2022|155